Trigg M E
University of Iowa Hospitals and Clinics, College of Medicine, University of Iowa, Iowa City 52242.
Am J Pediatr Hematol Oncol. 1993 May;15(2):141-9. doi: 10.1097/00043426-199305000-00001.
Bone marrow transplantation has been used with increasing frequency for the treatment of children with leukemia that is resistant to conventional therapy or in cases that have initial features indicating a poor prognosis.
For those children who are in need of a transplant but who do not have a matched sibling as bone marrow donor, transplantation can be performed with marrow from either a closely matched unrelated donor or from a partially matched family member.
Comparable results have been reported for transplants using either one of these alternative types of donor marrow, but these results are not as good as those using HLA-matched siblings as donors.
Delays in engraftment, increased infection rates, and complications related to graft-versus-host disease makes transplants using marrow from alternative donors more difficult and less successful. Improved methods to control graft-versus-host disease and greater ability to prevent infections, particularly opportunistic viral infections, will increase the success rate for marrow transplants using alternative donors. In addition, expansion of the National Marrow Donor Registry increases the likelihood of finding unrelated donors for children requiring such transplants.
骨髓移植越来越频繁地用于治疗对传统疗法耐药的白血病患儿,或用于那些具有初始特征表明预后不良的病例。
对于那些需要进行移植但没有匹配的同胞作为骨髓供体的儿童,可以使用来自密切匹配的无关供体或部分匹配的家庭成员的骨髓进行移植。
使用这两种替代类型的供体骨髓进行移植的报告结果相当,但这些结果不如使用 HLA 匹配的同胞作为供体的结果好。
植入延迟、感染率增加以及与移植物抗宿主病相关的并发症使得使用替代供体的骨髓进行移植更加困难且成功率更低。改进控制移植物抗宿主病的方法以及更强的预防感染能力,尤其是机会性病毒感染的能力,将提高使用替代供体进行骨髓移植的成功率。此外,扩大国家骨髓捐赠者登记处增加了为需要此类移植的儿童找到无关供体的可能性。